Viral hepatitis: yesterday, today, tomorrow
- Autores: Makashova V.V.1, Nikitina T.S.1, Ponezheva Z.B.1
-
Afiliações:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Edição: Volume 13, Nº 2 (2023)
- Páginas: 83-87
- Seção: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/558672
- DOI: https://doi.org/10.18565/epidem.2023.13.2.83–7
- ID: 558672
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
In this year, the Central Research Institute of Epidemiology is 60 years old. The paper presents the scientific activity of the Clinical Department and its divisions from the late 1970s to the present day. The main scientific works conducted under the guidance of scientists, such as Professors A.V. Zmyzgov and A.R. Reizis, are highlighted. At this time, they began to actively studied the cellular and humoral components of immunity, the hemostatis system, the state of the antioxidant system and lipid peroxidation, to test new therapies, such as hyperbaric oxygenation, plasmapheresis, laser therapy, interferons, etc. in patients with viral hepatitis.
Texto integral
Sobre autores
Vera Makashova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Autor responsável pela correspondência
Email: veramakashova@yandex.ru
ORCID ID: 0000-0002-0982-3527
MD, Professor, Leading Researcher
Rússia, MoscowTatyana Nikitina
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: nikitina-ts@mail.ru
ORCID ID: 0009-0004-5627-2424
Cand. Med. Sci., Academic Secretary
Rússia, MoscowZhanna Ponezheva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: doktorim@mail.ru
ORCID ID: 0000-0002-6539-4878
MD, Head, Clinical Department of Infectious Pathology
Rússia, MoscowBibliografia
- Blumberg B.S., Alter H.J., Visnich S.A. A new antigen in leukemia sera. JAMA 1965; 191: 541.
- Dane D.S., Cameron K.H., Brig M. Virus-like particles in the blood serum of patients with Australian antigen-associated hepatitis. Lancet 1970; 1(7649): 695–8. doi: 10.1016/s0140-6736(70)90926-8. PMID: 4190997
- Rizzetto M., Canese M.G., Aricò S., Crivelli O., Trepo C., Bonino F. et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18(2): 997–1003. — doi: 10.1136/gut.18.12.997. PMID: 75123
- Press release: The Nobel Prize in Physiology or Medicine 2020. https://www.nobelprize.org/prizes/medicine/2020/press-release/
- http://86.rospotrebnadzor.ru/news/28-iyulya-vsemirnyj-den-borby-s-gepatitom-28-07-2022
- http://www.cardio.by/ponimanie-virusnogo-gepatita-kak-globalnoy-problemi-zdravoohraneniya
- https://www.who.int/ru/campaigns/world-hepatitis-day/2022
- https://imunofan.ru/intervyu-professora-cznii-epidemiologii-minzdrava-rossii-v-v-lebedeva/
- Понежева Ж.Б., Макашова В.В., Маннанова И.В. Хронический гепатит С: современные аспекты эпидемиологии, иммунопатогенеза и терапии. /Под ред. В.Г. Акимкина. М.: Медконгресс, 2021. 84 с. Ponezheva Zh.B., Makashova V.V., Mаnnanova I.V. [Chronic hepatitis C: modern aspects of epidemiology, immunopathogenesis and therapy]. /V.G. Аkimkin, еd. Moscow: Medical Congress, 2021. 84 p.
Arquivos suplementares
